UK to receive 10 million AstraZeneca COVID-19 vaccine doses from India's Serum Institute

FILE PHOTO: A health worker holds a vial with doses of the Oxford-AstraZeneca vaccine, marketed by the Serum Institute of India (SII) as COVISHIELD, against the coronavirus disease (COVID-19), in Paramaribo, Suriname February 23, 2021. REUTERS/Ranu Abhelakh

(Reuters) - The UK will receive 10 million AstraZeneca COVID-19 vaccine doses made by the Serum Institute of India (SII), the UK government said in a statement on Tuesday.

SII, the world's largest vaccine manufacturer by volume, is mass producing the AstraZeneca vaccine, developed with Oxford University, for dozens of poor and middle-income countries.